Avinash Ravindranath Shenoy

Avinash Ravindranath Shenoy

Auto-generated profile, based on publicly available information

Avinash Ravindranath Shenoy

Imperial College London

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2012 in Science
Verified
Journal Article
Closed access
PDF file
ASAvinash R. Shenoy
Avinash R. Shenoy
DWDavid A. Wellington
David A. Wellington
PKPradeep Kumar
Pradeep Kumar
HKHilina Kassa
Hilina Kassa
CBCarmen J. Booth
Carmen J. Booth
JMJohn D. MacMicking
John D. MacMicking
Generating Inflammasomes: Inflammasomes are large, multiprotein complexes that assemble in response to infection that are also involved in the pathogenesis of a variety of other diseases, including type 2 diabetes and atherosclerosis. The assembly of the inflammasome triggers an inflammatory cascade that results in the activation of caspase-1 and production of the cytokines interleukin-1 and -18. Very little, however, is known about the specific signals that trigger inflammasome assembly. Shenoy et al. (p. 481, published online 29 March; see the Perspective by Caffrey and Fitzgerald ) now show that guanylate binding protein 5 (GBP5) promotes the assembly of the NLRP3-containing inflammasome in response to certain activation signals, such as pathogenic bacteria and adenosine triphosphate, but not others, like crystalline stimuli. Mice deficient in GBP5 exhibited impaired caspase-1 activation and production of cytokines. NLRP3 inflammasome–dependent responses to pathogenic bacteria and inflammatory stimuli were also impaired in mice lacking GBP5.

6 May 2011 in Science
Verified
Journal Article
Closed access
PDF file
BKBae-Hoon Kim
Bae-Hoon Kim
ASAvinash R. Shenoy
Avinash R. Shenoy
PKPradeep Kumar
Pradeep Kumar
RDRituparna Das
Rituparna Das
STSangeeta Tiwari
Sangeeta Tiwari
JMJohn D. MacMicking
John D. MacMicking
Guanylate-binding proteins coordinately regulate oxidative and autophagic responses to intracellular bacteria.

1 October 2012 in Cell Host & Microbe
Verified
Journal Article
Closed access
BKBae-Hoon Kim
Bae-Hoon Kim
ASAvinash R. Shenoy
Avinash R. Shenoy
PKPradeep Kumar
Pradeep Kumar
CBClinton J. Bradfield
Clinton J. Bradfield
JMJohn D. MacMicking
John D. MacMicking

3 September 2015 in Nature Nanotechnology
Verified
Journal Article
Open access
PDF file
SSSunaina Surana
Sunaina Surana
ASAvinash R. Shenoy
Avinash R. Shenoy
YKYamuna Krishnan
Yamuna Krishnan
This Perspective reviews the molecular, cellular and organismal response pathways that nucleic acid nanodevices are likely to interact with when deployed in living systems, and outlines ways to design nanodevices that either evade or react to the host response. DNA is proving to be a powerful scaffold to construct molecularly precise designer DNA devices. Recent trends reveal their ever-increasing deployment within living systems as delivery devices that not only probe but also program and re-program a cell, or even whole organisms. Given that DNA is highly immunogenic, we outline the molecular, cellular and organismal response pathways that designer nucleic acid nanodevices are likely to elicit in living systems. We address safety issues applicable when such designer DNA nanodevices interact with the immune system. In light of this, we discuss possible molecular programming strategies that could be integrated with such designer nucleic acid scaffolds to either evade or stimulate the host response with a view to optimizing and widening their applications in higher organisms.

3 June 2019 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
DFDaniel Fisch
Daniel Fisch
HBHironori Bando
Hironori Bando
BCBarbara Clough
Barbara Clough
VHVeit Hornung
Veit Hornung
MYMasahiro Yamamoto
Masahiro Yamamoto
EFEva‐Maria Frickel
Eva‐Maria Frickel
The guanylate binding protein (GBP) family of interferon‐inducible GTPases promotes antimicrobial immunity and cell death. During bacterial infection, multiple mouse Gbps, human GBP2, and GBP5 support the activation of caspase‐1‐containing inflammasome complexes or caspase‐4 which trigger pyroptosis. Whether GBPs regulate other forms of cell death is not known. The apicomplexan parasite Toxoplasma gondii causes macrophage death through unidentified mechanisms. Here we report that Toxoplasma ‐induced death of human macrophages requires GBP1 and its ability to target Toxoplasma parasitophorous vacuoles through its GTPase activity and prenylation. Mechanistically, GBP1 promoted Toxoplasma detection by AIM2, which induced GSDMD‐independent, ASC‐, and caspase‐8‐dependent apoptosis. Identical molecular determinants targeted GBP1 to Salmonella‐ containing vacuoles. GBP1 facilitated caspase‐4 recruitment to Salmonella leading to its enhanced activation and pyroptosis. Notably, GBP1 could be bypassed by the delivery of Toxoplasma DNA or bacterial LPS into the cytosol, pointing to its role in liberating microbial molecules. GBP1 thus acts as a gatekeeper of cell death pathways, which respond specifically to infecting microbes. Our findings expand the immune roles of human GBPs in regulating not only pyroptosis, but also apoptosis.

21 August 2015 in Nature Reviews Immunology
Verified
Journal Article
Closed access
PDF file
SMSerge Mostowy
Serge Mostowy
ASAvinash R. Shenoy
Avinash R. Shenoy